STE
STERIS plc · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website eris.com
- Employees(FY) 17000
- ISIN IE00BFY8C754
Performance
-4.12%
1W
-2.13%
1M
-13.12%
3M
-3.67%
6M
-4.71%
YTD
-2.54%
1Y
Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Technical Analysis of STE 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-17 19:00
STE: Lowering target price to $220.00(Argus Research)
- 2024-12-17 11:48
- 2024-12-10 19:00
STE: Lowering target price to $225.00(Argus Research)
- 2024-12-06 11:31
- 2024-12-03 19:00
STE: What does Argus have to say about STE?(Argus Research)
- 2024-11-27 09:40
- 2024-11-26 19:00
STE: Raising target price to $227.00(Argus Research)
- 2024-11-12 19:00
STE: Lowering target price to $234.00(Argus Research)
- 2024-11-11 09:15
- 2024-11-08 11:56
- 2024-11-08 09:02
Analyst Report: STERIS plc(Morningstar Research)
- 2024-11-08 02:17
- 2024-11-08 00:12
Decoding Steris PLC (STE): A Strategic SWOT Insight(GuruFocus.com)
- 2024-11-07 22:55
Q2 2025 STERIS plc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-07 11:21
- 2024-11-07 09:20
- 2024-11-06 19:00
- 2024-11-06 17:55
- 2024-11-06 17:45
- 2024-11-06 16:47
Steris: Fiscal Q2 Earnings Snapshot(Associated Press Finance)
- 2024-11-06 16:30
- 2024-11-06 03:30
- 2024-11-05 19:00
STE: Raising target price to $239.00(Argus Research)
- 2024-11-03 09:15
Is Now The Time To Look At Buying STERIS plc (NYSE:STE)?(Simply Wall St.)
- 2024-11-01 09:15
- 2024-10-31 09:25
- 2024-10-31 04:30
STERIS Declares Dividend of $0.57 per share(Globenewswire)
- 2024-10-30 16:30
STERIS Declares Dividend of $0.57 per share(GlobeNewswire)
- 2024-10-30 10:01
- 2024-10-24 05:27
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.